Why Agenus Stock Is Crushing It Today
2/3 20:10
What happened Shares of clinical-stage immunotherapy company Agenus (NASDAQ: AGEN) were up by a healthy 18% as of 1:09 p.m. ET on Wednesday. Investors are bidding up the biotech's stock today following the release of its 2021 fourth-quarter and full-year earnings report....